Bristol-Myers Squibb Company
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $3.32B | $2.68B | $1.09B | $2.20B | $1.31B | $2.46B | $72.0M | $1.21B |
| Depreciation & Amortization | $594.0M | $594.0M | $977.0M | $1.01B | $1.01B | $1.01B | $1.88B | $2.59B |
| Depreciation | $139.0M | $139.0M | $132.0M | $159.0M | $165.0M | $165.0M | $169.0M | $166.0M |
| Amortization | $471.0M | $472.0M | $906.0M | $867.0M | $864.0M | $863.0M | $1.80B | $2.40B |
| Stock-Based Compensation | $135.0M | $146.0M | $133.0M | $139.0M | $137.0M | $144.0M | $120.0M | $129.0M |
| Net Cash from Operating Activities | $3.39B | $1.10B | $1.97B | $6.31B | $3.92B | $1.95B | $4.44B | $5.59B |
| Investing Activities | ||||||||
| Capital Expenditures | $305.0M | $347.0M | $370.0M | $320.0M | $361.0M | $260.0M | $378.0M | $324.0M |
| Business Acquisitions | $91.0M | $65.0M | $1.71B | $1.87B | $285.0M | $78.0M | $47.0M | $348.0M |
| Net Cash from Investing Activities | $-1.61B | $-131.0M | $-1.46B | $-1.70B | $-473.0M | $-499.0M | $-196.0M | $-219.0M |
| Financing Activities | ||||||||
| Dividends Paid | $1.29B | $1.28B | $1.26B | $1.26B | $1.26B | $1.26B | $1.22B | $1.22B |
| Stock Repurchases | — | — | — | — | — | — | $0 | $0 |
| Net Cash from Financing Activities | $-2.63B | $-1.56B | $-6.03B | $-1.49B | $-1.84B | $-993.0M | $-1.64B | $-3.85B |
| Net Change in Cash | $-861.0M | $-635.0M | $-5.51B | $3.12B | $1.74B | $528.0M | $2.45B | $1.60B |
| Free Cash Flow | $3.09B | $757.0M | $1.60B | $5.99B | $3.56B | $1.69B | $4.06B | $5.27B |